The Franciscan Healthy Living Center, which opened in 2020, is designed to help those who’ve been through cancer, heart disease, surgery or other serious conditions improve their health factors, including diet, fitness, sleep and mental health.
The 44-acre campus will span approximately eight square blocks in downtown Indianapolis, replacing Methodist and University hospitals.
Kimball plans to occupy 307,000 square feet in the 584,820-square-foot Commerce Center Building 1, which was constructed in 2023 on South Post Road.
Lilly in February announced plans to add four U.S. manufacturing sites at yet-to-be-determined sites as part of a roughly $27 billion investment.
The Rely Center will move into a refurbished portion of the Aspire Indiana Health’s facility on Cumberland Road.
The Tobias-Lechleiter Institute will focus on getting more Hoosiers enrolled in clinical trials and advancing medical research at IU Health and the IU School of Medicine.
Biden was seen last week by doctors after urinary symptoms and a prostate nodule was found.
Diversity, equity and inclusion, or DEI, efforts have become a debated topic in the corporate world and beyond this year.
The Zimmer Biomet Oxford Cementless Partial Knee System received FDA approval in November, although the implant has been used in more than 300,000 procedures outside the U.S.
The Indiana Supreme Court has ruled that appeals of expired commitments are not moot if any potential collateral consequences remain.
Olio offers a software platform that allows health systems, physician groups and insurers to coordinate patient care across different settings.
The Swiss pharmaceutical and diagnostics giant said the move will establish the Indianapolis-based Roche Diagnostics site as a hub for manufacturing of its continuous glucose monitoring system.
The company has announced more than $50 billion in new U.S. manufacturing investments since 2020.
The idea, floated by the White House as a way to help pay for the president’s tax cut plan, blindsided the pharmaceutical industry and has prompted a furious lobbying campaign.
Chief Scientific Officer Dr. Daniel Skovronsky talked with the IBJ about his hopes for the Lilly Medicine Foundry, which the Indianapolis-based drugmaker broke ground on this week.
The 62-year-old company, which has moved into the prescription drug weight loss business, hopes to emerge from bankruptcy within 45 days.
Officials from the Indianapolis-based drugmaker said the Lilly Medicine Foundry will help streamline the process of discovering new medicines and getting them to patients.
House Bill 1004’s core pricing scrutiny targets hospital systems with $2 billion or more in net patient service revenue in the state.
Greenfield-based Elanco Health on Monday announced the $295 million cash sale of future U.S. royalty and milestone rights for the human use of a medication typically used for dogs and cats.
Carmel-based Forté Sports Medicine and Orthopedics now has 26 physicians and five offices in the Indianapolis area,
